Glaucoma secondary to topical use of steroid cream.
thoe Schwartzenberg
G W
GW
Department of Ophthalmology, University of Toronto, Ont.
Buys
Y M
YM
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001624:Betamethasone Valerate / Q000009:adverse effects* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy; D004060:Diflucortolone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004485:Eczema / Q000188:drug therapy; D005141:Eyelid Diseases / Q000188:drug therapy; D005260:Female; D005901:Glaucoma / Q000139:chemically induced* / Q000188:drug therapy; D005938:Glucocorticoids; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D009824:Ointments; D012607:Scotoma / Q000139:chemically induced; D014794:Visual Fields
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; C013486:diflucortolone valerate; D001624:Betamethasone Valerate; D004060:Diflucortolone